Phase I/II – Other

632 trials 274 recruiting

Filter these 632 trials by condition, country, sponsor and more.

Open in Search →

A combined treatment with GM-CSF, fosfomycin and metronidazole for pouchitis in ulcerative colitis patients after restorative ileal pouch an… Recruiting

2024-517764-38-00 Pouchitis 2024-09-27
Substudy 06D: Combination Therapies in 2L Advanced Gastroesophageal Adenocarcinoma Recruiting

2023-509306-29-00 Gastroesophageal cancer 2024-09-26
Substudy 06C: Combination Therapies in Gastroesophageal Adenocarcinoma Recruiting

2023-509307-33-00 Gastroesophageal cancer 2024-09-26
[68Ga]Ga-PentixaFor positron emission tomography for improved risk and disease assessment in myeloma Recruiting

2022-501811-14-00 Multiple Myeloma 2024-09-20
PREOPANC-5 Recruiting

2023-508707-20-00 Borderline resectable pancreatic cancer (BRPC) 2024-09-19
SAFETY AND POTENTIAL EFFECT OF INNOVATIVE CELL-BASED THERAPY USING ADIPOSE-DERIVED STROMAL VASCULAR FRACTION IN PATIENTS WITH AUTOIMMUNE XER… Recruiting

2023-505149-20-00 AUTOIMMUNE XEROSTOMIA 2024-09-13
A Phase I/II Study of Neoadjuvant, Intra-arterial Administration of [177Lu]Lu-PSMA-617 in Subjects with High-risk, Localised or Locally Adva… Recruiting

2022-500838-28-00 high-risk localized or locally advanced prostate cancer 2024-09-10
Improved breast cancer therapy (I-BCT-1) in the neoadjuvant and metastatic setting: A phase 2 clinical trial protocol studying biological ra… Recruiting

2024-515087-31-00 Breast cancer 2024-09-10
A clinical trial to be conducted in many hospitals and in different countries with the medicinal substance Regadenoson to be used in a type … Recruiting

2024-515244-22-00 Patients who need to undergo a clinically indicated pha 2024-09-09
Study in children and adolescents for the treatment of recurrent or relapsed solid tumours with the treatment of Lutathera® combined with ol… Recruiting

2024-512613-40-00 Recurrent or relapsed solid tumours expressing somatost 2024-08-28
MB-CART19.1 in refractory SLE Recruiting

2023-507654-33-00 Refractory systemic lupus erythematosus (SLE) 2024-08-12
A Trial to Learn if Linvoseltamab is Safe and Works in Adults with Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis) Recruiting

2023-507809-34-00 Relapsed or Refractory Systemic Light Chain Amyloidosis 2024-08-07
A clinical study of MK-2870 alone or with other treatments to treat gastrointestinal cancers (MK-9999-02A) Recruiting

2023-508703-21-00 Colorectal cancer (CRC), pancreatic ductal adenocarcino 2024-08-01
A Long-term Follow-up Study of Subjects With Malignancies Treated With CRISPR CAR Cellular Therapies Recruiting

2024-512479-11-00 Solid Malignancy 2024-07-26
PHASE IB/II CLINICAL TRIAL EVALUATING THE SAFETY AND EFFICACY OF CHEMOIMMUNOTHERAPY PLUS SHORT COURSE OF MEK INHIBITOR IN FIRST LINE OF TREA… Recruiting

2023-508477-87-00 Patients with localy advanced or metastatic non squamou 2024-07-24
EXLIBRIS : “EXL-01 combined with nivolumab for advanced NSCLC refractory to immunotherapy” Recruiting

2023-505285-28-01 Patients (male or female) ≥18 years old with histologic 2024-07-16
Dose Escalation and Dose Expansion Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Patients with Advanced … Recruiting

2023-508178-27-00 Participants with Advanced KRASG12C-Mutated Solid Tumor 2024-07-10
OSAGE : Phase I-II study chemoradiation in elderly patients with oesophagus cancer Recruiting

2024-514998-21-00 cancer de l'oesophage 2024-07-10
Phase I/II, open-label, multi-center study to evaluate the safety and efficacy of glyco-humanized polyclonal antibody directed against tumor… Recruiting

2023-509648-88-00 Peripheral T cells lymphoma (PTCL) 2024-07-09
Pan-lesions SBRT combined with lymphocyte support through ATRA-driven blockade of MDSC in patients with oligometastatic solid cancer (LySATR… Recruiting

2022-500680-13-00 Oligometastatic solid cancer 2024-07-04
TRAUMACELL - Effects of intravascular administration of mesenchymal stromal cells derived from Wharton’s Jelly of the umbilical cord on syst… Recruiting

2023-504415-33-00 Patients aged 15 years and 3 months and older with seve 2024-06-25
INJECTABL-II trial: Dose finding, efficacy and immunological response of a novel immuno-adjuvant (IP-001) following microwave ablation or ir… Recruiting

2023-504572-25-00 Colorectal liver metastases 2024-06-25
Dose-finding for dobutamine during transitional circulation in the very preterm infant Recruiting

2023-504915-34-00 Neonates with haemodynamic insufficiency 2024-06-20
Choice Of the Most Active Strategies for Short term recurring Triple Negative Breast Cancer A phase Ib/II, open-label, modular, dose-finding… Recruiting

2023-503606-36-00 Patients with hormone-receptor negative and HER2-negati 2024-06-17